vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.

Northfield Bancorp, Inc. is the larger business by last-quarter revenue ($41.3M vs $38.9M, roughly 1.1× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs -1545.5%, a 1570.2% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 12.7%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 15.0%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.

CDXS vs NFBK — Head-to-Head

Bigger by revenue
NFBK
NFBK
1.1× larger
NFBK
$41.3M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+68.7% gap
CDXS
81.3%
12.7%
NFBK
Higher net margin
CDXS
CDXS
1570.2% more per $
CDXS
24.7%
-1545.5%
NFBK
More free cash flow
NFBK
NFBK
$33.0M more FCF
NFBK
$52.5M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
15.0%
NFBK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
NFBK
NFBK
Revenue
$38.9M
$41.3M
Net Profit
$9.6M
$-27.4M
Gross Margin
94.8%
Operating Margin
27.1%
-1263.3%
Net Margin
24.7%
-1545.5%
Revenue YoY
81.3%
12.7%
Net Profit YoY
192.5%
-343.6%
EPS (diluted)
$0.13
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
NFBK
NFBK
Q4 25
$38.9M
$41.3M
Q3 25
$8.6M
$39.2M
Q2 25
$15.3M
$38.9M
Q1 25
$7.5M
$34.8M
Q4 24
$21.5M
$36.7M
Q3 24
$12.8M
$31.8M
Q2 24
$8.0M
$31.5M
Q1 24
$17.1M
$31.3M
Net Profit
CDXS
CDXS
NFBK
NFBK
Q4 25
$9.6M
$-27.4M
Q3 25
$-19.6M
$10.8M
Q2 25
$-13.3M
$9.6M
Q1 25
$-20.7M
$7.9M
Q4 24
$-10.4M
$11.3M
Q3 24
$-20.6M
$6.5M
Q2 24
$-22.8M
$6.0M
Q1 24
$-11.5M
$6.2M
Gross Margin
CDXS
CDXS
NFBK
NFBK
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
NFBK
NFBK
Q4 25
27.1%
-1263.3%
Q3 25
-220.3%
37.7%
Q2 25
-83.9%
35.6%
Q1 25
-271.6%
31.0%
Q4 24
-34.2%
38.0%
Q3 24
-129.0%
27.9%
Q2 24
-284.9%
29.1%
Q1 24
-69.6%
27.2%
Net Margin
CDXS
CDXS
NFBK
NFBK
Q4 25
24.7%
-1545.5%
Q3 25
-228.1%
27.4%
Q2 25
-86.6%
24.6%
Q1 25
-274.3%
22.6%
Q4 24
-48.4%
30.7%
Q3 24
-160.8%
20.5%
Q2 24
-285.2%
18.9%
Q1 24
-67.4%
19.9%
EPS (diluted)
CDXS
CDXS
NFBK
NFBK
Q4 25
$0.13
$-0.68
Q3 25
$-0.22
$0.27
Q2 25
$-0.16
$0.24
Q1 25
$-0.25
$0.19
Q4 24
$-0.12
$0.27
Q3 24
$-0.29
$0.16
Q2 24
$-0.32
$0.14
Q1 24
$-0.16
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
NFBK
NFBK
Cash + ST InvestmentsLiquidity on hand
$78.2M
$164.0M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$690.1M
Total Assets
$147.8M
$5.8B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
NFBK
NFBK
Q4 25
$78.2M
$164.0M
Q3 25
$58.7M
$131.7M
Q2 25
$66.3M
$97.6M
Q1 25
$59.8M
$101.7M
Q4 24
$73.5M
$167.7M
Q3 24
$90.3M
$232.9M
Q2 24
$73.2M
$153.5M
Q1 24
$85.5M
$238.8M
Total Debt
CDXS
CDXS
NFBK
NFBK
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
$666.4M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
NFBK
NFBK
Q4 25
$50.5M
$690.1M
Q3 25
$38.5M
$719.6M
Q2 25
$55.6M
$710.3M
Q1 25
$49.6M
$711.1M
Q4 24
$66.9M
$704.7M
Q3 24
$73.4M
$699.6M
Q2 24
$61.4M
$693.0M
Q1 24
$79.3M
$698.4M
Total Assets
CDXS
CDXS
NFBK
NFBK
Q4 25
$147.8M
$5.8B
Q3 25
$124.0M
$5.7B
Q2 25
$138.2M
$5.7B
Q1 25
$128.9M
$5.7B
Q4 24
$149.0M
$5.7B
Q3 24
$148.2M
$5.7B
Q2 24
$132.0M
$5.7B
Q1 24
$149.6M
$5.9B
Debt / Equity
CDXS
CDXS
NFBK
NFBK
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
0.95×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
NFBK
NFBK
Operating Cash FlowLast quarter
$20.1M
$53.7M
Free Cash FlowOCF − Capex
$19.6M
$52.5M
FCF MarginFCF / Revenue
50.3%
127.1%
Capex IntensityCapex / Revenue
1.3%
2.8%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$89.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
NFBK
NFBK
Q4 25
$20.1M
$53.7M
Q3 25
$-7.7M
$13.9M
Q2 25
$-18.0M
$14.1M
Q1 25
$-13.8M
$9.4M
Q4 24
$-16.5M
$31.1M
Q3 24
$-13.0M
$14.0M
Q2 24
$-12.2M
$6.9M
Q1 24
$-7.8M
$4.2M
Free Cash Flow
CDXS
CDXS
NFBK
NFBK
Q4 25
$19.6M
$52.5M
Q3 25
$-7.9M
$13.6M
Q2 25
$-20.5M
$13.9M
Q1 25
$-15.1M
$9.2M
Q4 24
$-18.2M
$30.0M
Q3 24
$-14.0M
$13.7M
Q2 24
$-12.6M
$6.7M
Q1 24
$-8.9M
$3.8M
FCF Margin
CDXS
CDXS
NFBK
NFBK
Q4 25
50.3%
127.1%
Q3 25
-91.7%
34.6%
Q2 25
-133.6%
35.7%
Q1 25
-199.6%
26.3%
Q4 24
-85.0%
81.6%
Q3 24
-109.0%
43.2%
Q2 24
-157.5%
21.1%
Q1 24
-52.2%
12.1%
Capex Intensity
CDXS
CDXS
NFBK
NFBK
Q4 25
1.3%
2.8%
Q3 25
2.1%
0.8%
Q2 25
16.4%
0.6%
Q1 25
16.7%
0.7%
Q4 24
8.3%
3.1%
Q3 24
7.8%
0.7%
Q2 24
5.0%
0.8%
Q1 24
6.6%
1.4%
Cash Conversion
CDXS
CDXS
NFBK
NFBK
Q4 25
2.09×
Q3 25
1.29×
Q2 25
1.48×
Q1 25
1.20×
Q4 24
2.76×
Q3 24
2.14×
Q2 24
1.16×
Q1 24
0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons